The Next Wave of
Neurological Medicines is Here.

We are committed to transforming the lives of patients with neurological and rare diseases.

Learn More

We’re Changing the Game.

We are developing a pipeline of potentially best-in-class neurological assets discovered and optimized by a world-class G protein-coupled receptors (GPCRs) research team at Arena Pharmaceuticals. Many important categories of drugs target GPCRs, which are proteins that regulate numerous aspects of human physiology. Longboard is leveraging 20 years of research to develop the next generation of GPCR-targeted medicines.

Learn more

Recent Press Releases

4.1.2022

Longboard Pharmaceuticals to Present Phase 1 Data for LP352 at the American Academy of Neurology Annual Meeting

03.03.2022

Longboard Pharmaceuticals Provides Corporate Update and Reports Full Year 2021 Financial Results

01.05.2022

Longboard Pharmaceuticals to Present at the H.C. Wainwright BioConnect Virtual Conference

View More

Live the
Longboard Life.

We are committed to improving the quality of life for individuals with devastating neurological conditions and strive to be the best possible teammates and colleagues. Learn more about our culture, benefits and open positions.

We show up
for patients.

The people living with, supporting and treating those with neurological conditions are at the center of what we do. Learn more about our commitment.